U.K. researchers studied 104,605 children born from 1990 to 2016 whose mothers were prescribed one macrolide antibiotic (erythromycin, clarithromycin or azithromycin) or one penicillin antibiotic from the fourth week of pregnancy to delivery.
Researchers observed major malformations in 186 of 8,632 children whose mothers were prescribed macrolides, representing a rate of 21.55 per 1,000 births. Among the 95,973 children whose mothers were prescribed penicillins during pregnancy, 1,666 developed major malformations, a rate of 17.36 per 1,000 births.
Taking a macrolide antibiotic during the first trimester was associated with an increased risk of any major malformation compared with penicillin, specifically cardiovascular malformations. Also, macrolide prescriptions in any trimester was linked with an increased risk of genital malformations.
More articles on patient safety and outcomes:
Depression can last up to a year after a stroke, study finds
CMS: 2 patient deaths resulted from failures by Kansas hospital staff
Medicare spent $41M+ on sepsis in 2018, HHS says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
